EFPIA MAPPs - newsletter  

masthead

E-NEWSLETTER
May 26th, 2015
littlesq
Interview
littlesq  
Sarah-Garner Get Real: Using real world data for decision-making in R&D and health technology assessment

Real world evidence holds the potential to both increase efficienty in R&D and to bridge the gap between the proof of efficacy required to pass regulatory scrutiny and the demonstration of likely effectiveness needed to satisfy health technology assessment bodies, says Professor Sarah Garner, Association Director for Science Policy and Research at NICE.

Various projects and pilots are in train to develop new methodologies and tools under the Medicines Adaptive Pathways to Patients (MAPPs) banner. NICE is involved in a number of these initiatives, including the Innovative Medicines Initiative's (IMI) GetReal project.


READ MORE...
littlesq
MAPPs Workshop
littlesq  
efpia amlittlesq MAPPs: Saving Time, Saving Lives
Luxembourg - June 4th, 2015 - 11:00-12:30 CET 

Medicines Adaptive Pathways to Patients (MAPPs) will provide patients who have unmet medical needs more timely access to new therapies, and will do so within the current regulatory framework. The workshop will take place in the context of the EFPIA Annual Meetings, which are centred on the theme of big data for better health outcomes.

Read the full programme
here.

Featuring:

  • Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency (EMA)
  • Karin Van Baelen, Head Global Regulatory Affairs at Janssen, J&J
  • Luk Maes, Executive Director Regulatory Europe, Bristol-Myers Squibb
  • James Anderson, Head of Corporate Government Affairs, GlaxoSmithKline, UK
  • Sue Forda, VP-Global Regulatory Affairs - International, Eli Lilly
  • Nathalie Seigneuret, Senior Scientific Project Manager, Innovative Medicines Initiative
  • Jeremy Haigh, Chair, EFPIA MAPPs Task Force (moderator)

READ MORE...

 
Join the Discussion
littlesq  
MAPPS LinkedInlittlesq New MAPPs Group Launches on LinkedIn

A new MAPPs group has been launched on LinkedIn. Join the group to get the latest updates on MAPPs, and to take part in the conversation.

JOIN THE DISCUSSION...
 
Request Your Invitation
littlesq  
BSBH-small 3

 
Better Science, Better Health: New Healthcare Models
Washington D.C. - October 27th - 28th 

There are multiple global initiatives currently investigating ways to improve and accelerate the way we bring needed new medicines to patients. How do we collaborate internationally to quantify uncertainty and harness real world evidence for better decision making and create better patient outcomes?

Featuring:  
  • Marc Berger, Vice President, Real World Data and Analytics, Pfizer
  • Magda Chlebus, Director Science Policy, EFPIA
  • Ruxandra Draghia-Akli, Director Health, DG Research and Innovation, European Commission
  • Hans-Georg Eichler, Senior Medical Officer, European Medicine’s Agency
  • Gigi Hirsch, Executive Director, MIT NewDig
  • Barbara Lopez Kunz, Global CEO, DIA
  • Irene Norstedt, Acting Executive Director, Innovative Medicine’s Initiative
  • Kenneth A. Oye, Associate Professor of Political Science and Engineering Systems, MIT
  • Vijay Pillai, Vice President, Oracle Health Sciences Network
  • Mark Trusheim, Researcher, MIT Sloan School of Management

READ MORE...

 
Survey
littlesq  
survey-newsletter KUL Survey - Adaptive Pathways

Please take the KU Leuven survey on Adaptive Pathways - your opinion counts! Completing this questionnaire will take only 10 minutes of your time.

TAKE THE SURVEY...

 
 
Upcoming events
littlesq  
euapm 3littlesq 4
 
STEPS in the Right Direction to a Brave New, Healthier & SMART Europe
June 2-3 2015, Brussels

The European Alliance for Personalised Medicine look forward to welcoming you to our third annual conference, to be held at the University Foundation in Brussels on 2-3 June. The conference will focus on the fact that health policies need to recognise and tackle the inherent health system vulnerabilities faced, specifically, by smaller countries and in the regions of the larger ones. This is the SMART approach – Smaller Member states And Regions Together; and this will be further developed at the conference.

READ MORE

   
OSLO HTAi 2

 
Workshop: Adaptive Pathways, Opportunities, Challenges and Solutions for Health Technology Assessment? (WS06)
June 13th 2015, Oslo

Participants are invited to contribute through an interactive workshop that aims to identify the role of HTA in an adaptive system and to develop practical recommendations to overcoming some of the challenges of adaptive pathways.

READ MORE

 
diatopra
 
Advanced Pathways Workshop
June 30th 2015, Brussels

This workshop aims to look into both the regulatory hurdles as well as discuss improvements in the market access based on evidence from recent years and situation in European countries.

READ MORE

 
EFPIA Brussels Office
littlesq  
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: anna.szczepanska@efpia.eu or science-policy@efpia.eu 
littlesq

footer

littlesq

 




Click to view this email in a browser

If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe

Vital Transformation
107 Leopold III Laan
Wezembeek-Oppem, 1970
Belgium

Read the VerticalResponse marketing policy.

Try Email Marketing with VerticalResponse!